(Q49019912)

17 February 2018

title

Alpha-synuclein is not a requisite component of synaptic boutons in the adult human central nervous system. (English)

1 reference

17 February 2018

1 reference

Braak H

1

1 reference

17 February 2018

Del Tredici K

series ordinal

2

1 reference

17 February 2018

Gai WP

series ordinal

3

1 reference

17 February 2018

Braak E

series ordinal

4

1 reference

17 February 2018

publication date

1 December 2000

1 reference

17 February 2018

Journal of Chemical Neuroanatomy

published in

1 reference

17 February 2018

volume

20

1 reference

17 February 2018

issue

3-4

1 reference

17 February 2018

page(s)

245-252

1 reference

17 February 2018

Immunoelectron-microscopic demonstration of NACP/alpha-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta-amyloid plaque cores.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Demonstration of Amyloid Deposits and Neurofibrillary Changes in Whole Brain Sections

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Silver staining method for demonstrating Lewy bodies in Parkinson's disease and argyrophilic oligodendrocytes in multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Neuropathological hallmarks of Alzheimer's and Parkinson's diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Neuropathology of synuclein aggregates

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Alpha-synuclein in Lewy body disease and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Parkinsonism: onset, progression, and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

The synaptic protein NACP is abnormally expressed during the progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Identification of two distinct synucleins from human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

1 reference

7 January 2021

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

1 reference

7 January 2021

Polyethylene glycol embedding: a technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Alpha-synuclein in Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies: implications for the pathogenesis of Parkinson disease and Lewy body dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0891-0618%2800%2900101-0

7 January 2021

10.1016/S0891-0618(00)00101-0

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018